Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism BACE1 inhibitors(Beta-secretase 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC31H38N4O5S |
InChIKeyVPNIQGRFZCTBEZ-SPTGULJVSA-N |
CAS Registry797035-11-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 1 | US | 01 Oct 2011 | |
Mild cognitive disorder | Phase 1 | US | 01 Oct 2011 |